Trial [resa]
atorvastatin [orch, phsu]
Rheumatoid Arthritis [dsyn]
DOUBLE BLIND [resa]
placebo-controlled [resa]
Trial [resa]
Rheumatoid Arthritis [dsyn]
Inflammatory [ftcn]
Synovitis [dsyn]
joint destruction [fndg]
Accelerated [ftcn]
Atherogenesis [patf]
HMG-CoA [bacs, orch]
3-hydroxy-3-methylglutaryl-coenzyme A [bacs, orch]
Reductase [aapp, enzy]
inhibitors [chvf]
Statins [orch, phsu]
Mediate [socb]
vascular [bpoc]
Risk Reduction [inbe]
Patients [podg]
Inflammatory disease [dsyn]
function [phsf]
Statins [orch, phsu]
Inflammatory [ftcn]
Rheumatoid Arthritis [dsyn]
MODIFY [ftcn]
vascular [bpoc]
Methods [inpr]
Patients [podg]
Rheumatoid Arthritis [dsyn]
DOUBLE BLIND [resa]
placebo-controlled [resa]
Trial [resa]
Receive [qlco]
mg% [qnco]
atorvastatin [orch, phsu]
placebo [topp]
Antirheumatic Drugs, Disease-Modifying [phsu]
therapy [ftcn]
Patients [podg]
Over [spco]
months [tmco]
activity [dora]
variables [qlco]
Circulating [ftcn]
vascular factor [aapp]
Measured [qlco]
activity [dora]
Score [qnco]
Proportion [qnco]
Meeting [hlca]
European [popg]
Rheumatism [dsyn]
Response [orga]
criteria [inpr]
Intention [menp]
findings [ftcn]
months [tmco]
Improved [qlco]
atorvastatin [orch, phsu]
Cl - [elii]
Compared [acty]
placebo [topp]
Group [idcn]
Cl - [elii]
P NOS [aapp, imft]
Response [orga]
Patients [podg]
atorvastatin [orch, phsu]
Compared [acty]
Six [qnco]
placebo [topp]
Odds Ratio [qnco]
cl-42 [gngm]
P NOS [aapp, imft]
C-reactive protein [aapp, imft]
Erythrocyte Sedimentation Rate [lbpr]
Relative [famg]
placebo [topp]
P NOS [aapp, imft]
P NOS [aapp, imft]
Swollen joint count [inpr]
Fall [fndg]
Cl - [elii]
P NOS [aapp, imft]
adverse events [fndg]
Occurred [acty]
frequency [qnco]
Patients [podg]
atorvastatin [orch, phsu]
placebo [topp]
Interpretation [inpr]
Statins [orch, phsu]
Mediate [socb]
apparent [idcn]
Anti-inflammatory effect [qlco]
Modification [ftcn]
vascular factor [aapp]
Context [fndg]
High grade [qlco]
Autoimmune [patf]
Inflammation [patf]
